{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihzlynclmbmcpbrebe5cxro232kvo77q7ph36wc2lmaj2sharmdy4",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mouzdnoi7gc2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiddejecbyrxi2q6kyacwjw54fd6ylqkzecsyzjyfchpmzmngz2fou"
    },
    "mimeType": "image/jpeg",
    "size": 29659
  },
  "path": "/2026/06/22/biotech-news-another-big-deal-another-sign-ma-is-back/?utm_campaign=rss",
  "publishedAt": "2026-06-22T13:21:46.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "drug development",
    "Drug prices",
    "research"
  ],
  "textContent": "AbbVie buys Apogee Therapeutics, LSD therapy Phase 3 results, and more biotech news from The Readout",
  "title": "STAT+: Another big deal, another sign biotech M&A is back",
  "updatedAt": "2026-06-22T13:21:51.000Z"
}